Clinical Trial Update: Minimizing Pain During Office Intradetrussor Botox Injection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing methods to minimize pain during office intradetrusor Botox injections for overactive bladder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder
• Urge Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Boston Urogynecology Associates | Conditions: Overactive Bladder, Overactive Detrusor | Phase 4 | Status: COMPLETED | Results posted: 2025-03-06